Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
The Scientist Marketing Team | May 20, 2014 | 2 min read
Technical challenges in procuring, isolating, and deriving stem cells exist, as do the ethical controversies around the use of stem cells. This webinar brings together a panel of experts to discuss hope, the hype, and what we can realistically expect to see going forward.
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board